AHA today urged the Antitrust Division of the Department of Justice to investigate thoroughly Centene's proposed acquisition of WellCare “because it threatens to reduce competition in delivery of Medicaid managed care and Medicare Advantage services to tens of millions of consumers across broad swaths of the country.” The letter notes, “There is no service more important to American consumers than health care, and vigorous competition among health insurance companies is necessary to ensure that consumers receive high quality at affordable rates. The facts show that the WellCare-Centene transaction is likely to significantly reduce competition and will therefore harm the most vulnerable Americans. DOJ should vigorously review this transaction's effects on current and future competition and take all appropriate measures to protect U.S. consumers.”

Related News Articles

Perspective
Public
One year ago, a nurse at Children’s Hospital Colorado went above and beyond in a way that a very young patient and her family will never forget. Kayla…
Headline
Achieving operational and survey readiness on day one is an issue that many health care facilities professionals continue to grapple with, according to…
AHA Cyber Intel
While the rate of cyberattacks on hospitals has risen dramatically, the severity of the impacts has also grown exponentially. Let’s look at the state of cyber…
Headline
The Department of Justice March 27 announced it is launching an Anticompetitive Regulations Task Force to advocate for “the elimination of anticompetitive…
Headline
The AHA March 10 filed a friend-of-the-court brief in the U.S. District Court for the Northern District of Illinois, urging the court to oppose a motion by…
Headline
The AHA Feb. 24 filed a friend-of-the-court brief in the Supreme Court, urging the court to reverse a ruling by the U.S. Court of Appeals for the 5th Circuit…